Your cart is currently empty.
GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound are leading a weight loss revolution. Even though these drugs come with well-known side effects, more doctors than ever are recommending them to eligible patients in 2025.
So why are GLP-1s being prescribed so widely—especially when nausea, fatigue, and other digestive symptoms are common? The answer lies in the results, and the growing medical evidence that benefits outweigh the side effects for most people.
What Are GLP-1 Side Effects?
Doctors are transparent about the common side effects associated with GLP-1 medications. These typically include:
- Nausea
- Constipation or diarrhea
- Fatigue
- Loss of appetite
- Bloating or belching
- Mild headache
Most of these effects occur in the early weeks of treatment and often subside as the body adjusts to the medication.
Why Doctors Still Recommend GLP-1s in 2025
Despite the above, doctors are prescribing GLP-1 medications more frequently because:
1. The Weight Loss Results Are Unmatched
GLP-1s help patients lose 15%–20% of their body weight on average—results that previously required surgery or extreme dieting.
2. Side Effects Are Manageable
Providers start patients at low doses and gradually increase them to reduce risk of nausea or GI symptoms. This titration strategy works well for most.
3. Better Outcomes in Metabolic Health
GLP-1s don’t just help with weight—they also improve insulin resistance, blood sugar, and inflammation, making them valuable even for prediabetic or non-diabetic patients.
4. Clinical Guidance Makes It Safer
Telehealth services like Meya provide expert support throughout treatment, helping patients manage side effects early and avoid dropping out of therapy.
Why Side Effects Are Worth It for Many Patients
The discomfort some patients experience at the start is temporary. But the health benefits—weight loss, improved energy, reduced joint pain, and lower disease risk—are long-term.
Doctors now recognize that:
- A few weeks of nausea is manageable compared to years of obesity-related issues
- Patients are more motivated than ever to stick with treatment
- Support tools and patient education have improved significantly
How to Start GLP-1 Treatment With Medical Support
Platforms like Meya allow patients to:
- Complete a medical intake online
- Get approved by licensed providers
- Receive compounded semaglutide or tirzepatide
- Pay only $196/month—no insurance needed
- Get help managing side effects and dosage
This approach gives patients both affordability and expert supervision.
Conclusion: Doctors Are All-In on GLP-1s in 2025
Even with potential side effects, doctors in 2025 are recommending GLP-1s more than ever before. The results speak for themselves, and with careful management, the majority of patients tolerate the treatment well.
Want real GLP-1 treatment without the $1,300/month price tag? Start your journey with Meya for just $196/month.
